Related Experiment Video
Updated: Jul 11, 2026

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
Published on: March 9, 2018
Response of central nervous system aspergillosis to voriconazole
Prakash Balasubramaniam1, Pranesh B Madakira, Anish Ninan
1Department of Neurology, PSG Institute of Medical Sciences and Research, Avinasi Road, Peelamedu, Coimbatore - 641 002, India.
Abstract:
Fungal infections of the central nervous system (CNS) usually present as subacute meningitis. Other manifestations include mass effect and focal neurological deficits. Cerebrospinal fluid (CSF) examination and biopsy of the lesion are helpful in disclosing the organism involved. Aspergillosis presents as brain abscess or granuloma with predominant neutrophils in CSF. Voriconazole is a broad spectrum triazole antifungal agent. It can be given orally and has lesser adverse effects We report a 69-years-old diabetic male, with aspergilloma of para-nasal sinus invading the CNS, who responded well to voriconazole treatment. He discontinued the medication by himself as it was costly. Within a month of stopping the medication, he developed features of subacute meningitis. However he showed clinical improvement after the medication was restarted. The case is reported for the clinical evidence of antifungal activity of voriconazole against aspergillosis.
Insights
This case study highlights voriconazole
Area of Science:
- Mycology
- Infectious Diseases
- Neurology
Background:
- Fungal infections of the central nervous system (CNS) often manifest as subacute meningitis.
- Aspergillosis can present as brain abscess or granuloma, with CSF analysis showing neutrophils.
Observation:
- A 69-year-old diabetic male with CNS aspergilloma invading from the para-nasal sinus was treated with voriconazole.
- The patient experienced relapse of subacute meningitis symptoms upon self-discontinuation of voriconazole due to cost.
- Restarting voriconazole led to clinical improvement.
Findings:
- Voriconazole demonstrated clinical efficacy in treating CNS aspergillosis.
- The case provides evidence for the antifungal activity of voriconazole against invasive aspergillosis.
Implications:
- Voriconazole is a viable oral treatment option for CNS aspergillosis.
- Treatment adherence is crucial for managing invasive fungal infections of the CNS.
Related Concept Videos
Antifungal Agents
Cryptococcal Meningitis
Candidiasis
Fungal Phylum Ascomycota
Drug Toxicity: Allergic Reactions
Hypersensitivity Reactions: Cytolytic Reactions
